About
Strategic biotech leader with 12 years of experience across sequencing, process…
Experience
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
-
Boston University School of Medicine
-
-
Activities and Societies: Boston University Chinese Students and Scholars Association
-
-
-
-
-
-
-
-
-
Courses
-
Biochemistry
-
-
Biochemistry
-
-
Biostatistics
-
-
Botany
-
-
Cell Biology
-
-
Cinematography
-
-
Clinical Nutrition
-
-
Epidemiology
-
-
Microbiology
-
-
Molecular Bioglogy
-
-
Nutrition and Metabolism
-
-
Photography
-
-
Proteomics
-
-
Zoology
-
Languages
-
English
Full professional proficiency
-
Chinese
Native or bilingual proficiency
-
Japanese
Professional working proficiency
Other similar profiles
Explore more posts
-
Vincent Zucconi
🚀🔬 Agilent Technologies just dropped a $950M bombshell — acquiring Biocare Medical to massively expand its footprint in clinical pathology & companion diagnostics! 🌟🩺 This move brings Biocare’s robust immunohistochemistry (IHC) portfolio, high-quality antibodies, detection reagents and automated staining solutions directly into Agilent’s ecosystem — supercharging offerings for cancer diagnostics, biomarker discovery and precision oncology workflows worldwide. With Biocare’s strong presence in the US pathology lab market and Agilent’s global scale in molecular & tissue diagnostics, this is a clear power play to dominate the growing IHC & digital pathology space. “Biocare Medical is a perfect strategic fit — adding deep expertise in IHC and a loyal customer base that will accelerate Agilent’s leadership in pathology and precision medicine.” – Agilent leadership, on why this acquisition is a major step toward end-to-end cancer diagnostics dominance! 🔥🧬 From instruments to antibodies to full pathology solutions — Agilent is building a diagnostics powerhouse right in front of our eyes. Who do you think benefits most from this deal: pathologists, oncologists, or patients? 🤔👇💬
1 Comment
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top content